Search
for
Sort by
Research 871–900 of 1000+
- Use of Myoinositol in PCOS
- Postmenopausal ovarian hyperandrogenism of surgically treated patients: a case report and scoping review with individual patient’s data analysis
- Updates in Treatment for Androgenetic Alopecia
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- Androgenetic Alopecia in Men: An Update On Genetics
- Testosterone: The Male Sex Hormone
- Endocrinology
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Simplify your approach to the diagnosis and treatment of PCOS
- Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?
- Evaluation of Serum Testosterone, Cholesterol and Plasma Glucose Concentrations in Hirsute Women in Bayelsa State
- Dermatologic care of patients with differences of sex development
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- Polycystic Ovary Syndrome and Reproductive Health: A Comprehensive Review
- Congenital Adrenal Hyperplasia
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- PPAR‐γ signalling as a key mediator of human hair follicle physiology and pathology
- Polycystic Ovary Syndrome (PCOS) and Fertility
- The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
- Cutaneous manifestations of endocrine diseases in children
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study
- Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- Growth Hormone and the Human Hair Follicle
- The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
- Polycystic ovary syndrome in Singapore
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists